Pursuant to CSA Instruments Governing Relief Due to Covid-19 (BC Instrument 51-515 and Alberta Blanket Order 51-517)
Vancouver, BC, March 31, 2020, - Zecotek Photonics Inc. (“Zecotek” or the “Company”) (TSX-V: ZMS, Frankfurt: W1I, OTCPK: ZMSPF) announces that, due to circumstances created by the COVID – 19 pandemic, it will not be filing its Financial Statements for the three months ended January 31, 2020 by the scheduled due date of March 31, 2020 (as required by section 4.4(b) of National Instrument 51-102), or the Management Discussion and Analysis covering the same period (as required by section 5.1(2) of National Instrument 51-102). The Company has been experiencing delays in obtaining financial information from its operating entities in China due to the earlier onset of the COVID-19 virus in that part of the world and the resulting impact on business operations there. The Company has also been adjusting to circumstances relating to the more recent outbreak of the pandemic in North America. The Company is working with its operating entities to assist with the preparation of the required financial information and hopes to file the required financial reports as soon as possible.
As required by BC Instrument 51-515 and Alberta Blanket Order 51-517, the Company discloses the following:
• The Company’s management and other insiders will be subject to a trading black-out that reflects the principles in Section 9 of National Policy 11-207 until its Financial Statements for the three months ended January 31, 2020 and the related the Management Discussion and Analysis (the “Financial Reports”) have been filed;
• The Company expects to file the Financial Reports on or about May 15, 2020; and
• Other than as previously disclosed by the Company, there have been no material business developments since the date of the Company’s most recent filing of its interim Financial Statements and Management Discussion and Analysis.
Faouzi Zerrouk CEO / Director Zecotek Photonics Inc.
About Zecotek Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF) is a photonics technology company developing high-performance scintillation crystals, solid-state photo detectors, 3D displays and related technologies for applications in medical, high-tech and industrial sectors. Founded in 2004, Zecotek has three operating divisions: Zecotek Imaging China, Zecotek Optronics Systems, and Zecotek Autotronics with labs located in Canada, Korea, Russia, Singapore and U.S.A. It is commercializing over 55 patented and patent pending novel photonic technologies directly and through strategic alliances with the Shanghai EBO Optoelectronics Technology Company (China), Hamamatsu Photonics (Japan), the European
Organization for Nuclear Research (Switzerland), NuCare Medical Systems (South Korea), the University of Washington (United States), and National NanoFab Center (South Korea). For more information visit www.zecotek.com and follow @zecotek on Twitter.
This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. The use of any of the words “may”, “will”, “hopes”, “plans”, “expects” and similar expressions are intended to identify forward-looking information or statements. Although the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward looking statements and information because the Company can give no assurance that they will prove to be correct. By its nature, such forward-looking information is subject to various risks and uncertainties, which could cause actual results to differ materially from the anticipated results or expectations expressed herein. These risks and uncertainties, include, but are not limited to access to capital markets, market forces, competition from new and existing companies and regulatory conditions. Readers are cautioned not to place undue reliance on this forward-looking information, which is given as of the date it is expressed in this news release or otherwise. The Company undertakes no obligation to update publicly or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by law.
For Additional Information Please Contact: Zecotek Photonics Inc. Tel: +1 604-783-8291 Email: [email protected] Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future, please visit the corporate website at www.zecotek.com.